Hosted on MSN1mon
Reasons to Retain Inari Medical Stock in Your Portfolio for NowImage Source: Zacks Investment Research Inari Medical has positioned itself as a leader in the treatment of venous thromboembolism (VTE) through its innovative ClotTriever and FlowTriever products.
Hosted on MSN11mon
Why You Should Retain Inari Medical (NARI) Stock for NowInari Medical, Inc. NARI is well-poised for ... Triever16 Curve is the latest addition to NARI’s FlowTriever platform. The latest launches are expected to significantly solidify the company ...
Inari’s core products, FlowTriever and ClotTriever, are designed to treat blood clots without the need for thrombolytic drugs, differing from competitor offerings. This innovation provides a ...
Inari Medical has a fifty-two week low of $ ... vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results